resultspreview:lookingfor+$13m ebitda&$54m rev, page-3

Agreed; earnings upgrade (positive) does assist a little to appease concern on underlying EBITDA detrioration for first half, which came in at 6% lower than last year. Ongoing higher payments to doctors chewing into result. Update makes a stronger reference to growth options being pursued. Interesting comments on surgeries in Qld - not sure if closure/exit being considered for two locations? EPS (core) appears to have bottomed at least at around 8 cents for full year.